Heart attacks and strokes are among the leading causes of death globally, with millions suffering from cardiovascular diseases (CVD) every year. There are more than seven million people in the UK alone, with about 100,000 patients experiencing heart attacks annually. However, a group of researchers at University College London (UCL) estimate that one 'polypill' taken daily day could eliminate a majority of these cases dramatically lowering death tolls.

The proposed polypill, a combination of a statin and three blood pressure-lowering drugs, has been under study for over two decades. Experts argue that introducing this pill universally for individuals aged 50 and above could be more effective than the current NHS Health Check, which assesses risk factors every five years for those aged between 40 and 74.

Studies have repeatedly proven the effectiveness of the polypill in preventing CVD. A groundbreaking 2019 study in The Lancet found that five years' use of the polypill cut the risk of heart attack and stroke by a third. In addition, previous modelling analyses have estimated that if given universally to people over 55, the polypill might be able to prevent 80% of heart attacks and strokes.

Today, the NHS Health Check follows a risk-based model in which patients are tested for CVD risk factors and treated with drugs accordingly. Yet, as per UCL's study, this system has serious flaws:

Low Uptake: Just 40% of those eligible for the NHS Health Check choose to have it, leaving a considerable number of at-risk patients undiagnosed and untreated.

Ineffective Prediction of Risk: The majority of heart attacks and strokes happen to people at average risk levels, thus making it challenging to identify the need for intervention effectively.

Limited Effectiveness: Even at maximum take-up, the NHS Health Check programme is predicted to have fewer health impacts compared to a polypill initiative applied to the whole population.

Simplicity and Affordability of the Polypill Strategy

One of the big benefits of the polypill is that it is so easy. In contrast to the existing screening-based model, the polypill scheme would not involve complicated medical tests or lengthy risk assessments. Instead, people reaching 50 would just have to fill out a few questions to determine possible side effects before they were prescribed.

Professor Aroon Hingorani of the UCL Institute of Cardiovascular Science, one of the strongest proponents of this scheme, says:

"Finally, the time is now to do much better on prevention. A population approach would prevent a lot more heart attacks and strokes than is done today with a strategy of trying to target a smaller group only."

Aside from the possible health implications, the polypill is also an economic solution. The drugs used are off-patent, thus cheap to produce and distribute. With the vast economic cost of managing CVD-related illnesses, a preventive model could result in substantial cost-saving for the NHS in the future.

The polypill has been proven to be effective by numerous international trials. In 2019, a randomised trial in rural Iran discovered that participants who took the polypill for five years had a 34% reduced risk of having a heart attack or stroke compared to non-participants.

Likewise, modelling research has indicated that even if only 8% of people aged over 50 took up the polypill regimen, it would still be more beneficial to their health than the NHS Health Check programme.

Is This a Case of Over-Medicalisation?

One of the main objections to the polypill strategy is the suggestion that it might result in the unnecessary medicalisation of a significant proportion of the population. But, it is argued, it should be considered as a preventative measure, not as mass medication.

Professor Sir Nicholas Wald of UCL's Institute of Health Informatics explains:

"Instead of being a 'medicalisation' of a significant proportion of the population, a polypill programme is a prevention measure to prevent an individual from becoming a patient."

He compares it with public health measures like water fluoridation or compulsory seatbelts—interventions that have been shown to have a significant impact in reducing public health danger at low individual cost.

With the evidence in favour of the polypill's effectiveness and viability overwhelming, experts are calling on the NHS to act now. It is their belief that substituting the NHS Health Check with a polypill-based prevention program could be the UK government's flagship policy under its pledge to put disease prevention ahead of cure.

As Professor Hingorani points out, "The status quo is not a justifiable option." With CVD still a major cause of death globally, taking a population-wide polypill approach could be a turning point for preventative medicine, potentially saving thousands of lives annually. The question now is whether the NHS will take up this call and establish a policy with the potential to transform the prevention of cardiovascular disease on a national level.

Prime Minister Narendra Modi today launched the nationwide Human Papillomavirus (HPV) vaccination campaign for girls aged 14 years from Rajasthan's Ajmer.

The initiative marks a decisive step towards eliminating cervical cancer through timely HPV vaccination. Cervical cancer remains the second most common cancer among women in India. Nearly 80,000 new cases and over 42,000 deaths are reported annually in the country.

"Today, I have had the opportunity to launch the HPV vaccine campaign from Ajmer. This campaign is an important step towards empowering women and daughters of this country,” PM Modi said.

“For us, this was a sensitive issue tied to the insult of our sisters and daughters, one that made them ill. That is why we resolved it at a crucial turning point in their mission,” he added.

The World Health Organization has also lauded India's mission to launch the HPV vaccine and prevent the risk of cervical cancer.

“We are leaving no stone unturned to ensure that the daughters of the country are healthy and prosperous. The objective of this initiative is the prevention of cervical cancer," the Prime Minister, earlier wrote in a post on social media platform X.

The HPV Vaccination Campaign

The nationwide program, based on expert recommendations of the National Technical Advisory Group on Immunization (NTAGI), will target girls aged 14 years.

At 14, the HPV vaccine offers maximum preventive benefit, well before potential exposure to the virus.

"By prioritizing prevention at the right age, the program is expected to provide lifelong protection and significantly reduce the future burden of cervical cancer in the country," the government said.

“The HPV vaccine works best at 9-14 years, before exposure, and when the immune response is strongest. Studies show effectiveness is highest in younger age groups and decreases with age,” Dr. Parmod Kumar, Associate Professor in Medical Oncology, AIIMS Jodhpur, shared on X.

Vaccination under the national program will be voluntary and free of cost.

The HPV vaccination will be conducted exclusively at designated government health facilities, including Ayushman Arogya Mandirs (Primary Health Centers), Community Health Centers, Sub-District and District Hospitals, and Government Medical Colleges.

Cervical Cancer Burden In South East Asia

Despite being preventable, cervical cancer continues to claim the life of a woman every two minutes globally, and the WHO South-East Asia Region bears nearly one-quarter of the global burden.

Dr. Catharina Boehme, Officer-in-Charge, WHO South-East Asia, stated that the introduction of HPV vaccination at a national scale in India "will have a far-reaching impact". It will accelerate progress not only for the country, but for the region and the world, she said.

“This landmark step, led at the highest level of government, reflects India’s strong commitment to protecting adolescent girls from cervical cancer," said Dr. Boehme.

With today’s milestone, nine of the 10 countries in the Region now include HPV vaccination in their national immunization programs.

The WHO global targets for 2030 include vaccinating 90 percent of girls by age 15, screening 70 percent of women by ages 35 and 45, and ensuring 90 percent of women with pre-cancer and invasive cancer receive appropriate treatment.

A team of doctors in Uttar Pradesh successfully performed a rare and highly complex neuro-interventional procedure on a two-and-a-half-year-old girl that enabled significant neurological recovery.

The child initially had severe indigestion and mild fever. However, it quickly escalated into repeated seizures, altered sensorium, and sudden loss of movement.

At ApolloMedics Super Speciality Hospital, Lucknow, the child was diagnosed with deep Cerebral Venous Sinus Thrombosis (CVST) with multiple brain infarcts -- a condition associated with high mortality risk and potentially devastating long-term neurological disability.

“Deep cerebral venous thrombosis in toddlers is exceptionally rare, and neuro-intervention in pediatric stroke is particularly challenging because of the small size of vessels and increased risk of bleeding,” said Dr. Dewansh Mishra, Interventional Neuro-Radiologist, at ApolloMedics.

“Literature on catheter-directed thrombolysis in such young patients is limited. In this case, the child was deteriorating quickly, and timely escalation to precision neuro-intervention was crucial to prevent irreversible brain injury and give her the best possible chance of recovery,” he added.

The Rare Brain Surgery

Dr. Mishra said that the child was also diagnosed with Antiphospholipid Antibody (APLA) syndrome, a clotting disorder that increases the tendency of blood to clot excessively.

Infection and dehydration further worsened the condition and accelerated stroke progression.

Recognizing the urgency, a multidisciplinary team of doctors took a critical, high-risk decision to escalate treatment without delay. They performed intracranial catheter-directed thrombolysis, under general anesthesia, preventing irreversible brain injury in the toddler.

Through the femoral vein in the thigh, a microcatheter was carefully navigated into the intracranial venous system, and clot-dissolving medication was delivered directly at the site of thrombosis to restore venous drainage. This was successful in limiting further neurological damage.

"After nearly three weeks of intensive care and rehabilitation, the child was discharged with significant neurological recovery. She is now able to walk, speak, and perform activities that children of her age do," the hospital said in a statement.

The case, marked by rapid deterioration and a narrow window for intervention, will be presented at the Indian National Stroke Conference 2026 in Kochi, underlining both its clinical significance and the growing capabilities of advanced stroke care in India.

Can Stroke Occur In Very Young Children?

While stroke is more common in adults than in children, the condition can occur in children and debilitate their lives.

Pediatric stroke is a rare condition affecting one in every 4,000 newborns and an additional 2,000 older children each year.

Stroke in young children is similar to that of adults and is caused by a brain injury due to the interruption of blood flow to part of the brain.

In young children, the diagnosis is often delayed. A stroke typically begins suddenly in children and infants, with Seizures the most common symptom.

Extreme sleepiness or altered mental status and a tendency to use only one side of the body are other major symptoms.

72 tigers have died due to an illness in Thailand's Chiang Mai. This happened is the span of less than two weeks this month. Facilities of Tiger Kingdom Chiang Mai, have been concerned, as this is a park where visitors can touch and interact with the big cats.

As per a BBC report, the local livestock department said that samples from tigers showed canine distemper virus. However, authorities have not yet confirmed how the outbreak happened. The samples were collected from tigers' bodies, the chicken they eat and their surroundings.

In a news conference, officials told that the virus was no longer spreading and that no more tigers were dying. The officials also stated that no humans had been infected.

The remains of the tigers have been buried and a recommendation was made for the gravely ill tigers to be euthanized, said the authorities. Somchuan Ratanamungklanon, director of the national livestock department, previously told local media, "By the time we realized they were sick, it was already too late." He noted that it was harder to detect the sickness in tigers compared to animals like common household cats or dogs.

Read: This Zoonotic Disease Of Himalayas Is Re-emerging But Recognition Remains Poor

Previously, the provincial livestock office had told that preliminary tests showed the tigers were infected with feline parvovirus. While some local officials also suspected that the outbreak was stemmed from contaminated raw chicken meat that was fed to tigers as per the Bangkok Post.

As per the Thai PBS report, none of the veterinarians or other staff working in the Chiang Mai tiger enclosures had fallen ill from canine distemper virus. However, the disease control department said that they have been placed under observation for 21 days.

Canine Distemper: The Virus That Killed 72 Tigers In Thailand

As per the American Veterinary Medical Association, canine distemper is a contagious and serious disease caused by the canine distemper virus. The virus attacks the respiratory, gastrointestinal, and nervous system of canines, including dogs, cats, and other wild canines, which includes foxes, wolves, tigers, big cats, raccoons, and skunks, etc.

The signs of canine distemper includes:

• Discharge from the eyes and nose
• Fever
• Coughing
• Lethargy
• Reduced appetite
• Vomiting
• Diarrhea

There are certain neurological signs too that can be noted:

• Walking in circles, unable to follow a straight path
• Head tilt
• Lack of coordination
• Muscle twitches
• Convulsions with jaw-chewing movements (“chewing gum fits”) and drooling
• Seizures
• Partial or complete paralysis

Is Canine Distemper Contagious to Humans?

As per PetMD, there is no evidence that humans can get canine distemper. Blue Cross UK also states that canine distemper virus is not infectious to humans and poses no known health threat to people. While it could be related to human measles virus, it does not cross over to cause illness in humans.

Read: Is There A Difference Between Zoonotic, Non-Zoonotic And Reverse Zoonotic Diseases

How Did The Tigers In Thailand Get Canine Distemper?

Many animal right groups are blaming the poor living conditions of captives as the reason for the virus. They say that tigers used for entertainment in Thailand lived in unclean enclosures. As per the Wildlife Friends Foundation Thailand, the tigers' deaths exposed the "extreme vulnerability of captive wildlife facilities to infectious disease". "Tragedies like this would be far less likely to happen" if tourists "stayed away" from these attractions, Peta Asia said in a statement.

Tiger Kingdom Chiang Mai has been temporarily closed for two weeks to carry out the disinfection work.